Berberine · 500 mg (from Berberis vulgaris)

Provides 500 mg of Berberine Hydrochloride per capsule—the exact dosage used in clinical trials for glucose and lipid control.

• Hypoglycemic Effects: Operates through multiple mechanisms, including the significant improvement of insulin sensitivity.

• Lipid Profile Support: Demonstrates favorable effects on blood lipids, including a reduction in triglycerides, total cholesterol, and LDL cholesterol.

• Nrf2 Activation: Activates Nrf2, a master regulator of antioxidant gene transcription, helping to prevent glucose-induced neurotoxicity.

• Premium Source: Extracted from Berberis vulgaris (European Barberry).

• Dietary Friendly: Suitable for vegetarians and vegans.

Clinical & Therapeutic Overview

Traditionally used to address gastrointestinal symptoms, Berberine has emerged as a powerful cardiometabolic adjuvant with diverse benefits and mechanisms of action.

Metabolic Mechanism

Berberine exerts its hypoglycemic effects by inhibiting alpha-glucosidase activity and increasing the expression of insulin receptors in peripheral tissues. This dual action directly enhances insulin sensitivity. Furthermore, by activating the Nrf2 pathway, it strengthens cellular antioxidant defenses and mitigates glucose-induced neurotoxicity, suggesting strong therapeutic potential for managing diabetic neuropathy.

Proven Efficacy

• Glycemic Control: In controlled trials, Berberine reduced HbA1c levels in diabetic participants with an efficacy comparable to metformin.

• Metabolic Syndrome & PCOS: For individuals with metabolic syndrome, it has been shown to reduce waist circumference, body weight, blood pressure, and triglycerides. Similar metabolic benefits have been observed in women dealing with PCOS (Polycystic Ovary Syndrome).

• Cardiovascular Protection: Beyond lowering total and LDL cholesterol, clinical research involving patients undergoing percutaneous coronary intervention showed that adding Berberine to standard treatment significantly improved several inflammatory markers, including C-Reactive Protein (CRP), IL-6, MMP-9, ICAM-1, and VCAM-1.